Pharma giant Eli Lilly confirmed plans for the plant in Houston where an oral GLP-1 weight loss drug could be made, creating ...
Eli Lilly and Co. (NYSE: LLY) confirmed Sept. 23 that the Bayou City will be part of its domestic manufacturing push. David ...
The multibillion-dollar investment will result in more than 600 permanent jobs, according to the company. The manufacturing ...
The pharmaceutical giant’s expansion into Texas will create 615 full-time jobs and receive $5.5 million in state funding.
In a major development for the Greater Houston economy, Fortune 100 drugmaker Eli Lilly has announced plans for a $6.5 ...
More production capacity for the obesity pill is crucial as Eli Lilly races to bring it to market and tries to maintain its ...
Eli Lilly's massive investment in Houston is even larger than it initially proposed just four months ago when it applied for ...
Eli Lilly plans to build a $6.5 billion factory in Houston, with construction expected to be completed by 2030.
Oral Ozempic alternative Orforglipron inspired the biggest biotech investment in Texas history, in Generation Park.
HOUSTON — Eli Lilly and Co. (NYSE: LLY) has unveiled plans to build a new $6.5 billion manufacturing facility at Generation ...
Eli Lilly announced plans to build a $6.5B pharmaceutical manufacturing facility in Houston's Generation Park.
Eli Lilly and Company plans to invest $6.5 billion to build a manufacturing facility at Generation Park in Houston, Texas.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results